Part 7/11:
The goal is to combine this magnetic field therapy with chemotherapy to increase cancer cell kill rates while reducing chemotherapy doses, thereby minimizing side effects. Currently, pre-clinical trials show promising results, with no adverse effects. The device must still undergo clinical trials to confirm safety and efficacy, particularly in early-stage breast cancer patients.
Expert Insight: Dr. Jolene Lim from the National University Cancer Institute highlighted the importance of the upcoming clinical trial, which aims to validate safety and effectiveness before broader implementation. If successful, this method could extend to other cancers sharing similar metabolic vulnerabilities.